Compliance of Therapeutic Regimen among Patients with Multiple Sclerosis
People with multiple sclerosis (MS) face challenges complying with disease-modifying drug (DMD) treatment. Poor compliance with treatment reduces its clinical effectiveness which can adversely impact disease progression, MS-related hospitalization.
Gespeichert in:
Veröffentlicht in: | NeuroQuantology 2022-01, Vol.20 (11), p.8196 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | People with multiple sclerosis (MS) face challenges complying with disease-modifying drug (DMD) treatment. Poor compliance with treatment reduces its clinical effectiveness which can adversely impact disease progression, MS-related hospitalization. |
---|---|
ISSN: | 1303-5150 |
DOI: | 10.14704/NQ.2022.20.11.NQ66812 |